参考文献/References:
[1] KARSENTY G,FERRON M.The contribution of bone to whole-organism physiology[J].Nature,2012,481(7381):314-320.
[2] WU J,DOU Y,LIU W,et al.Osteocalcin improves outcome after acute ischemic stroke[J].Aging(Albany NY),2020,12(1):387-396.
[3] BERGER J M,SINGH P,KHRIMIAN L,et al.Mediation of the acute stress response by the skeleton[J].Cell Metab,2019,30(5):890-902.
[4] SHI T,SHEN S,SHI Y,et al.Osteocyte-derived sclerostin impairs cognitive function during ageing and Alzheimer's disease progression[J].Nat Metab,2024,6(3):531-549.
[5] 徐伟丽,牛玲玲,王文侠,等.经典Wnt信号通路对骨代谢的调节作用[J].中国骨质疏松杂志,2016,22(3):376-380.
[6] RICHTER B,FAUL C.FGF23 actions on target tissues-with and without klotho[J].Front Endocrinol(Lausanne),2018,9:189.
[7] YANG S,WAGSTYL K,MENG Y,et al.Cortical patterning of morphometric similarity gradient reveals diverged hierarchical organization in sensory-motor cortices[J].Cell Rep,2021,36(8):109582.
[8] ZHANG Y,CHEN C Y,LIU Y W,et al.Neuronal induction of bone-fat imbalance through osteocyte neuropeptide Y[J].Adv Sci(Weinh),2021,8(24):e2100808.
[9] TAKAKURA A,LEE J W,HIRANO K,et al.Administration frequency as well as dosage of PTH are associated with development of cortical porosity in ovariectomized rats[J].Bone Res,2017,5:17002.
[10] CHEN F,OUYANG Y,YE T,et al.Estrogen inhibits RANKL-induced osteoclastic differentiation by increasing the expression of TRPV5 channel[J].J Cell Biochem,2014,115(4):651-658.
[11] WANG Y,NISHIDA S,ELALIEH H Z,et al.Role of IGF-1 signaling in regulating osteoclastogenesis[J].J Bone Miner Res,2006,21(9):1350-1358.
[12] BEIER E E,SHEU T J,RESSEGUIE E A,et al.Sclerostin activity plays a key role in the negative effect of glucocorticoid signaling on osteoblast function in mice[J].Bone Res,2017,5:17013.
[13] CORNISH J,CALLON K E,BAVA U,et al.Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo[J].J Endocrinol,2002,175(2):405-415.
[14] YANG C H,ANN-ONDA D,LIN X,et al.Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes[J].Mol Metab,2022,55:101413.
[15] ELEFTERIOU F,AHN J D,TAKEDA S,et al.Leptin regulation of bone resorption by the sympathetic nervous system and CART[J].Nature,2005,434(7032):514-520.
[16] BALDOCK P A,LIN S,ZHANG L,et al.Neuropeptide Y attenuates stress-induced bone loss through suppression of noradrenaline circuits[J].J Bone Miner Res,2014,29(10):2238-2249.
[17] SHI H,CHEN M.The brain-bone axis:unraveling the complexinterplay between the central nervous system and skeletal metabolism[J].Eur J Med Res,2024,29(1):317.
[18] YADAV V K,OURY F,SUDA N,et al.A serotonin-dependent mechanism explains the leptin regulation of bone mass,appetite,and energy expenditure[J].Cell,2009,138(5):976-989.
[19] YADAV V K,RYU J H,SUDA N,et al.Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum[J].Cell,2008,135(5):825-837.
[20] WANG C X,GE X Y,WANG M Y,et al.Dopamine D1 receptor-mediated activation of the ERK signaling pathway is involved in the osteogenic differentiation of bone mesenchymal stem cells[J].Stem Cell Res Ther,2020,11(1):12.
[21] WANG L,HAN L,XUE P,et al.Dopamine suppresses osteoclast differentiation via cAMP/PKA/CREB pathway[J].Cell Signal,2021,78:109847.
[22] OURY F,KHRIMIAN L,DENNY C A,et al.Maternal and offspring pools of osteocalcin influence brain development and functions[J].Cell,2013,155(1):228-241.
[23] NAKAMURA M,IMAOKA M,TAKEDA M.Interaction of bone and brain:osteocalcin and cognition[J].Int J Neurosci,2021,131(11):1115-1123.
[24] 李婷婷,陈凤,刘然.阿尔茨海默病患者血清FGF23和ZAG水平表达与认知功能的相关性分析[J].现代检验医学杂志,2023,38(6):166-169.
[25] 王依宁,廖子蔚,杜娟,等.脑小血管病患者血清3-NT、Hcy、PLR和FGF23水平与认知功能障碍的关系[J].分子诊断与治疗杂志,2023,15(4):665-668.
[26] 马晓伟,田伟,冯文霞,等.外周血Lp-PLA2和FGF23水平变化与脑梗死后认知功能障碍的相关性[J].中国实用神经疾病杂志,2024,27(4):463-467.
[27] DIVOLIS G,STAVROPOULOS A,MANIOUDAKI M,et al.Activation of both transforming growth factor-β and bone morphogenetic protein signalling pathways upon traumatic brain injury restrains pro-inflammatory and boosts tissue reparatory responses of reactive astrocytes and microglia[J].Brain Commun,2019,1(1):fcz028.
[28] 何辉,李雯,刘娟,等.骨形态发生蛋白/维甲酸诱导的神经特异性蛋白3在丙戊酸钠诱导神经干细胞向神经元分化过程中的作用[J].解剖学报,2020,51(6):832-838.
[29] 李红云,裴海涛,汝丽娟.骨形态发生蛋白-7对大鼠脑缺血再灌注后Caspase-3表达的影响[J].解剖学报,2012,43(3):335-339.
[30] UYGUR B,DUBERMAN J,FERGUSON S M.A guide to time lag and time lag shortening strategies in oncology-based drug development[J].J Commer Biotechnol,2017,23:75-81.
[31] ZHU S,PANG Y,XU J,et al.Endocrine regulation on bone by thyroid[J].Front Endocrinol(Lausanne),2022,13:873820.
[32] SUAREZ-BREGUA P,GUERREIRO P M,ROTLLANT J.Stress,glucocorticoids and bone:a review from mammals and fish[J].Front Endocrinol(Lausanne),2018,9:526.
[33] ZHANG L,LIU N,SHAO J,et al.Bidirectional control of parathyroid hormone and bone mass by subfornical organ[J].Neuron,2023,111(12):1914-1932.
[34] WANG T,HE C.TNF-α and IL-6:the link between immune and bone system[J].Curr Drug Targets,2020,21(3):213-227.
[35] MOGHADDASI M,NABOVVATI M,KOUSHKI A,et al.Randomized control trial of evaluation of Clemastine effects on visual evoked potential,nerve fiber layer and ganglion cell layer complex in patients with optic neuritis[J].Clin Neurol Neurosurg,2020,193:105741.
[36] SAILIKE B,ONZHANOVA Z,AKBAY B,et al.Vitamin D in central nervous system:implications for neurological disorders[J].Int J Mol Sci,2024,25(14):7809.
[37] KIM J M,PARK K Y,KIM H R,et al.Association of bone mineral density to cerebral small vessel disease burden[J].Neurology,2021,96(9):e1290-e1300.
[38] YAJUN W,JIN C,ZHENGRONG G,et al.Betaine attenuates osteoarthritis by inhibiting osteoclastogenesis and angiogenesis in subchondral bone[J].Front Pharmacol,2021,12:723988.
[39] REHMAN R,ALAM F,BAIG M,et al.Editorial:vitamin D deficiency and sufficiency in reproduction and bone metabolism[J].Front Endocrinol(Lausanne),2021,12:740021.
[40] SINISCALCHI A,MURPHY S,CIONE E,et al.Antiepileptic drugs and bone health:current concepts[J].Psychopharmacol Bull,2020,50(2):36-44.
[41] AGIRMAN G,YU K B,HSIAO E Y.Signaling inflammation across the gut-brain axis[J].Science,2021,374(6571):1087-1092.
[42] HEATH V.Pharmacotherapy:novel antibody therapy demonstrates potential for building bone in osteoporosis[J].Nat Rev Endocrinol,2014,10(3):125.
[43] 李希宁,董颖,赵宇,等.雷帕霉素通过抑制mTOR通路激活自噬缓解氟骨症大鼠早期的骨质疏松[J].中华劳动卫生职业病杂志,2021,39(5):321-327.